ORTHOPEDIATRICS CORP (KIDS) Latest Filing Signal

Latest Filing: 10-K  |  Filed Mar 4, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for ORTHOPEDIATRICS CORP?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, ORTHOPEDIATRICS CORP's filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-13.74%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Continuing Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does ORTHOPEDIATRICS CORP actually do?
Answer:
OrthoPediatrics Corp. is a global medical device company exclusively focused on the pediatric orthopedic market, designing and marketing anatomically appropriate implants, instruments, and specialized braces for children. The company addresses unmet needs in trauma and deformity correction, scoliosis, and sports medicine/other procedures, offering 87 surgical and bracing systems. OrthoPediatrics operates with a contract manufacturing model for implants and instruments, while manufacturing its orthopedic bracing products in-house. It also runs multiple orthotic and prosthetic (O&P) clinics. The company sells its products in over 75 countries, utilizing a network of independent sales agencies and distributors, and has expanded its direct sales presence in key international markets. OrthoPediatrics emphasizes surgeon collaboration, clinical education, and a culture focused on improving children's lives.
Question:
What are ORTHOPEDIATRICS CORP's revenue drivers?
Answer:
Revenue is primarily driven by the sale of orthopedic implants, instruments, and specialized bracing products used in pediatric trauma and deformity correction, scoliosis, and sports medicine procedures. The company also generates revenue from its orthotic and prosthetic (O&P) clinics.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required